[{"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-001", "question": "A 5-month-old infant presents with exaggerated startle response to noise, progressive motor regression, and bilateral macular cherry-red spots. Serum hexosaminidase A and B levels are within normal limits. Genetic sequencing reveals a mutation in the GM2A gene. Which of the following is the correct diagnosis?", "options": ["Tay-Sachs disease", "Sandhoff disease", "GM2 activator deficiency", "Sialidosis type I", "Niemann-Pick disease type A"], "answer": "C", "answer_index": 2, "explanation": "The clinical phenotype mimics Tay-Sachs (Hex A deficiency) and Sandhoff (Hex A and B deficiency) diseases, including the cherry-red spot and startle response. However, normal enzyme levels with a mutation in GM2A indicate the AB variant of GM2 gangliosidosis, caused by a deficiency in the GM2 activator protein required for the interaction between the lipid substrate and the enzyme.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\": The vignette describes a 5-month-old with classic GM2 gangliosidosis features (exaggerated startle, motor regression, cherry-red spots) but normal hexosaminidase A and B levels, with a GM2A mutation. This pattern defines GM2 activator deficiency (AB variant). The question asks for the correct diagnosis. Option C directly matches the molecular defect described. Option A (Tay-Sachs) would show low hexosaminidase A. Option B (Sandhoff) would show low hexosaminidase A and B. Option D (Sialidosis) is a neuraminidase deficiency with different biochemical profile. Option E (Niemann-Pick A) presents with hepatosplenomegaly and foamy macrophages, not cherry-red spots. The stem provides sufficient biochemical and genetic data to uniquely identify GM2 activator deficiency. The keyed answer is correct and defensible. No contradictions or missing critical details.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": ": The vignette describes a 5-month-old with classic GM2 gangliosidosis features (exaggerated startle, motor regression, cherry-red spots) but normal hexosaminidase A and B levels, with a GM2A mutation. This pattern defines GM2 activator deficiency (AB variant). The question asks for the correct diagnosis. Option C directly matches the molecular defect described. Option A (Tay-Sachs) would show low hexosaminidase A. Option B (Sandhoff) would show low hexosaminidase A and B. Option D (Sialidosis) is a neuraminidase deficiency with different biochemical profile. Option E (Niemann-Pick A) presents with hepatosplenomegaly and foamy macrophages, not cherry-red spots. The stem provides sufficient biochemical and genetic data to uniquely identify GM2 activator deficiency. The keyed answer is correct and defensible. No contradictions or missing critical details.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-002", "question": "A 3-day-old neonate presents with intractable seizures refractory to phenobarbital, phenytoin, and levetiracetam. The EEG shows a burst-suppression pattern. Administration of intravenous pyridoxine yields no improvement. Subsequent administration of pyridoxal-5'-phosphate results in immediate cessation of clinical and electrographic seizure activity. Which enzyme is deficient?", "options": ["Antiquitin (ALDH7A1)", "Pyridox(am)ine 5'-phosphate oxidase (PNPO)", "Glutamic acid decarboxylase (GAD)", "GABA transaminase", "Succinic semialdehyde dehydrogenase"], "answer": "B", "answer_index": 1, "explanation": "Pyridoxine-dependent epilepsy (ALDH7A1 deficiency) responds to pyridoxine. However, patients with PNPO deficiency cannot convert pyridoxine to the active form, pyridoxal-5'-phosphate (PLP). They present with similar intractable seizures but require PLP specifically for treatment.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\": \",\"logical_false_reason\":\"T\",\"logical_validity\":true,\"medical_accuracy_score\":\"5\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": ": ", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-003", "question": "A 35-year-old male with Myotonic Dystrophy Type 1 presents for emergency appendectomy. Following induction with propofol and succinylcholine, the patient develops generalized muscle rigidity, making ventilation impossible. The heart rate is 110 bpm and temperature is 37.2°C. Which of the following best explains the pathophysiology of this reaction?", "options": ["Uncontrolled calcium release from the sarcoplasmic reticulum via the ryanodine receptor", "Prolonged depolarization of the motor endplate causing sodium channel inactivation failure", "Exaggerated contracture due to sodium channel hyperexcitability distal to the neuromuscular junction", "Denervation hypersensitivity leading to massive potassium efflux", "Deficiency of pseudocholinesterase leading to prolonged blockade"], "answer": "C", "answer_index": 2, "explanation": "This is a succinylcholine-induced myotonic contracture, not Malignant Hyperthermia (MH). In myotonic dystrophy, the muscle membrane is hyperexcitable. Succinylcholine causes a sustained, generalized contracture that acts as a 'chemical splint,' preventing ventilation. Unlike MH, it is not mediated by the RYR1 receptor and does not respond to dantrolene.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\": \",\"logical_false_reason\":\"T\",\"logical_validity\":true,\"medical_accuracy_score\":\"4\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": ": ", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-004", "question": "A patient with a known diagnosis of Erythropoietic Protoporphyria (EPP) is undergoing a prolonged laparotomy. Which of the following intraoperative interventions is most critical to prevent cutaneous injury in this specific patient?", "options": ["Avoidance of nitrous oxide", "Placement of yellow filters over the operating lights", "Strict avoidance of volatile anesthetics", "Administration of high-dose corticosteroids", "Maintenance of normothermia to prevent precipitation"], "answer": "B", "answer_index": 1, "explanation": "Patients with EPP accumulate protoporphyrin IX, which is phototoxic upon exposure to light in the violet/blue spectrum (Soret band, ~400-410 nm). Standard operating lights emit significant energy in this range, causing severe phototoxic skin burns and potential intestinal injury during laparotomy. Yellow filters block this specific wavelength.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem correctly identifies a patient with Erythropoietic Protoporphyria (EPP) undergoing prolonged laparotomy, establishing the critical problem of phototoxic injury from operating lights. Key discriminating findings are the specific pathophysiology—protoporphyrin IX accumulation causing phototoxicity upon exposure to violet/blue light (Soret band, ~400-410 nm)—and the surgical context implying high-intensity light exposure. Option B (yellow filters) directly and uniquely addresses this mechanism by blocking the offending wavelength, making it the most critical intervention. Alternative options are clearly inferior: A (avoid nitrous oxide) and C (avoid volatile anesthetics) have no relevance to EPP phototoxicity; D (high-dose corticosteroids) is ineffective for acute photoprotection; and E (normothermia) confuses the mechanism and does not prevent phototoxic reactions. No internal contradictions exist, and the options permit clear discrimination. Medical accuracy is excellent: the phototoxic mechanism, wavelength specificity, and use of yellow filters are well-established in porphyria management guidelines. The item is clinically realistic and board-relevant. Minimal fix: none required; the item is unambiguous and accurate as written.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem correctly identifies a patient with Erythropoietic Protoporphyria (EPP) undergoing prolonged laparotomy, establishing the critical problem of phototoxic injury from operating lights. Key discriminating findings are the specific pathophysiology—protoporphyrin IX accumulation causing phototoxicity upon exposure to violet/blue light (Soret band, ~400-410 nm)—and the surgical context implying high-intensity light exposure. Option B (yellow filters) directly and uniquely addresses this mechanism by blocking the offending wavelength, making it the most critical intervention. Alternative options are clearly inferior: A (avoid nitrous oxide) and C (avoid volatile anesthetics) have no relevance to EPP phototoxicity; D (high-dose corticosteroids) is ineffective for acute photoprotection; and E (normothermia) confuses the mechanism and does not prevent phototoxic reactions. No internal contradictions exist, and the options permit clear discrimination. Medical accuracy is excellent: the phototoxic mechanism, wavelength specificity, and use of yellow filters are well-established in porphyria management guidelines. The item is clinically realistic and board-relevant. Minimal fix: none required; the item is unambiguous and accurate as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-005", "question": "A 45-year-old female with breast cancer is being treated with tamoxifen. She develops major depressive disorder. Which of the following antidepressants is contraindicated due to a pharmacokinetic interaction that would reduce the oncologic efficacy of her breast cancer treatment?", "options": ["Venlafaxine", "Escitalopram", "Paroxetine", "Desvenlafaxine", "Mirtazapine"], "answer": "C", "answer_index": 2, "explanation": "Tamoxifen is a prodrug that requires conversion to its active metabolite, endoxifen, primarily via the CYP2D6 enzyme. Paroxetine (and fluoxetine) is a potent CYP2D6 inhibitor, which can significantly lower endoxifen levels and potentially increase the risk of breast cancer recurrence. Venlafaxine and escitalopram have minimal effect on CYP2D6.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem clearly establishes tamoxifen as a CYP2D6-dependent prodrug requiring conversion to active endoxifen, and asks which antidepressant is contraindicated due to a pharmacokinetic interaction reducing oncologic efficacy. Paroxetine (option C) is a potent CYP2D6 inhibitor that would block this activation, directly answering the question. Alternative options are well-differentiated: venlafaxine, desvenlafaxine, escitalopram, and mirtazapine all have minimal CYP2D6 inhibition and are recommended as safer alternatives per major oncology guidelines. No internal contradictions exist, and the options permit clear discrimination based on established drug interaction profiles. Medical accuracy is gold-standard: the tamoxifen-CYP2D6 inhibitor interaction is robustly supported by pharmacokinetic studies and clinical guidelines (NCCN, ASCO, FDA labeling) that specifically advise avoiding paroxetine and fluoxetine. The item is clinically realistic, board-relevant, and contains no factual errors or outdated concepts. Minimal fix: None required; the item is ready for high-stakes examination use.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem clearly establishes tamoxifen as a CYP2D6-dependent prodrug requiring conversion to active endoxifen, and asks which antidepressant is contraindicated due to a pharmacokinetic interaction reducing oncologic efficacy. Paroxetine (option C) is a potent CYP2D6 inhibitor that would block this activation, directly answering the question. Alternative options are well-differentiated: venlafaxine, desvenlafaxine, escitalopram, and mirtazapine all have minimal CYP2D6 inhibition and are recommended as safer alternatives per major oncology guidelines. No internal contradictions exist, and the options permit clear discrimination based on established drug interaction profiles. Medical accuracy is gold-standard: the tamoxifen-CYP2D6 inhibitor interaction is robustly supported by pharmacokinetic studies and clinical guidelines (NCCN, ASCO, FDA labeling) that specifically advise avoiding paroxetine and fluoxetine. The item is clinically realistic, board-relevant, and contains no factual errors or outdated concepts. Minimal fix: None required; the item is ready for high-stakes examination use.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-006", "question": "A patient with schizophrenia is started on clozapine. Three weeks later, he presents with fever, tachycardia, and eosinophilia. A diagnosis of clozapine-induced myocarditis is suspected and confirmed. After recovery, the psychiatric team considers a rechallenge due to treatment resistance. Under current expert consensus guidelines, which medication should be co-administered during the rechallenge to reduce the risk of recurrence?", "options": ["Lithium", "Propranolol", "Prednisone", "Lisinopril", "Metoprolol"], "answer": "D", "answer_index": 3, "explanation": "While clozapine rechallenge after myocarditis is high-risk and generally discouraged, when deemed necessary, protocols often utilize an ACE inhibitor (like lisinopril) or an ARB prophylactically. This is based on the hypothesis that the renin-angiotensin-aldosterone system plays a role in the inflammatory/fibrotic pathogenesis of the myocarditis.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer under item's flawed premise. Key clues: classic clozapine myocarditis presentation (fever, tachycardia, eosinophilia), treatment-resistant schizophrenia prompting rechallenge consideration. The question misrepresents ACE inhibitor prophylaxis as 'expert consensus.' In reality, rechallenge after myocarditis is contraindicated per major guidelines (Maudsley, APA); prophylactic ACE inhibitor use is limited to isolated case reports and experimental protocols, lacking robust evidence or true consensus. Among options, lisinopril (D) is most defensible if accepting this premise—beta-blockers (B, E) lack supporting data, lithium (A) is irrelevant, and steroids (C) are not standard. Medical accuracy is compromised by overstating evidence strength, potentially misleading learners about a high-risk practice. Logical structure is sound: single best answer exists and matches key. Minimal fix: Change 'expert consensus guidelines' to 'some experimental protocols' and add explicit warning about lack of consensus and contraindication status per major guidelines.\",\"medical_accuracy_score\":  \"2\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer under item's flawed premise. Key clues: classic clozapine myocarditis presentation (fever, tachycardia, eosinophilia), treatment-resistant schizophrenia prompting rechallenge consideration. The question misrepresents ACE inhibitor prophylaxis as 'expert consensus.' In reality, rechallenge after myocarditis is contraindicated per major guidelines (Maudsley, APA); prophylactic ACE inhibitor use is limited to isolated case reports and experimental protocols, lacking robust evidence or true consensus. Among options, lisinopril (D) is most defensible if accepting this premise—beta-blockers (B, E) lack supporting data, lithium (A) is irrelevant, and steroids (C) are not standard. Medical accuracy is compromised by overstating evidence strength, potentially misleading learners about a high-risk practice. Logical structure is sound: single best answer exists and matches key. Minimal fix: Change 'expert consensus guidelines' to 'some experimental protocols' and add explicit warning about lack of consensus and contraindication status per major guidelines.", "medical_accuracy_score": 2, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-007", "question": "A 22-year-old male presents with hypersomnia, hyperphagia, and hypersexuality occurring in distinct episodes lasting two weeks, separated by months of normal behavior. During episodes, he exhibits derealization. Which of the following pharmacologic agents has the strongest evidence for preventing future episodes of this syndrome?", "options": ["Modafinil", "Lithium", "Methylphenidate", "Fluoxetine", "Lorazepam"], "answer": "B", "answer_index": 1, "explanation": "The clinical presentation is classic for Kleine-Levin Syndrome (KLS). While symptomatic treatment involves stimulants, Lithium is the mood stabilizer with the most reported efficacy in reducing the frequency and intensity of the cycling episodes, although evidence is limited to case series and small studies.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\": \"The vignette describes classic Kleine-Levin Syndrome (KLS): recurrent episodes of hypersomnia, hyperphagia, hypersexuality, and derealization in a young male. The question asks for prophylaxis, not acute symptomatic treatment. Among options, lithium (B) is the only agent with reported efficacy for reducing episode frequency/duration in KLS, supported by case series and small studies. Stimulants (modafinil, methylphenidate) treat acute hypersomnia but lack preventive evidence. Fluoxetine and lorazepam have no established role. Thus, lithium is uniquely defensible as the best answer, making the item logically valid. Medical accuracy is acceptable: while evidence for lithium is weak (low-quality observational data), it remains the consensus choice for prophylaxis in this rare disorder, and the rationale correctly acknowledges these limitations. The item accurately distinguishes symptomatic vs preventive therapy. No contradictions or underspecification. Minor limitation: the phrase 'strongest evidence' may overstate absolute evidence quality, but in relative terms among the options, it is correct. Minimal fix: add 'based on limited available evidence' to the stem for precision.\",\"medical_accuracy_score\":   \"4\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes classic Kleine-Levin Syndrome (KLS): recurrent episodes of hypersomnia, hyperphagia, hypersexuality, and derealization in a young male. The question asks for prophylaxis, not acute symptomatic treatment. Among options, lithium (B) is the only agent with reported efficacy for reducing episode frequency/duration in KLS, supported by case series and small studies. Stimulants (modafinil, methylphenidate) treat acute hypersomnia but lack preventive evidence. Fluoxetine and lorazepam have no established role. Thus, lithium is uniquely defensible as the best answer, making the item logically valid. Medical accuracy is acceptable: while evidence for lithium is weak (low-quality observational data), it remains the consensus choice for prophylaxis in this rare disorder, and the rationale correctly acknowledges these limitations. The item accurately distinguishes symptomatic vs preventive therapy. No contradictions or underspecification. Minor limitation: the phrase 'strongest evidence' may overstate absolute evidence quality, but in relative terms among the options, it is correct. Minimal fix: add 'based on limited available evidence' to the stem for precision.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-008", "question": "A 60-year-old female undergoes a laparoscopic cholecystectomy for symptomatic cholelithiasis. Final pathology reveals an incidental gallbladder adenocarcinoma invading the perimuscular connective tissue (T1b) without extension into the liver. The cystic duct margin is negative. What is the appropriate next step in management?", "options": ["Observation only", "Adjuvant chemotherapy with Gemcitabine/Cisplatin", "Radiation therapy to the gallbladder fossa", "Resection of liver segments IVb and V with portal lymphadenectomy", "Endoscopic Retrograde Cholangiopancreatography (ERCP) with stenting"], "answer": "D", "answer_index": 3, "explanation": "For T1a gallbladder cancer (invading lamina propria), simple cholecystectomy is curative. However, for T1b (invading muscle layer) and greater, there is a significant risk of lymph node metastasis and recurrence. The standard of care is radical cholecystectomy, which includes resection of the liver bed (segments IVb and V) and a portal lymphadenectomy.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid). Verdict: Correct best answer. Key stem clues: 60‑year‑old female, incidental gallbladder adenocarcinoma, T1b invasion of perimuscular connective tissue, negative cystic duct margin, no hepatic extension. These findings indicate an early but potentially node‑positive malignancy, mandating oncologic clearance. The keyed answer D (radical cholecystectomy with en‑bloc resection of liver segments IVb/V and portal lymphadenectomy) reflects the standard of care endorsed by NCCN and AJCC for T1b gallbladder cancer. Alternative options are clearly inferior: observation (A) undertreats nodal risk; adjuvant chemotherapy (B) or radiation (C) are not primary curative therapies for resectable T1b; ERCP with stenting (E) is palliative and inappropriate. The vignette contains no contradictory information and provides adequate detail to identify a single best answer. Medical accuracy: The distinction between T1a (simple cholecystectomy) and T1b (radical resection) is correct and aligns with current oncologic principles. While recent literature suggests select T1b cases may be managed with simple cholecystectomy alone, the item’s recommendation remains the consensus for board‑style assessment. No major inaccuracies. Minimal fix: None required.\",\"medical_accuracy_score\":  \t\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: Correct best answer. Key stem clues: 60‑year‑old female, incidental gallbladder adenocarcinoma, T1b invasion of perimuscular connective tissue, negative cystic duct margin, no hepatic extension. These findings indicate an early but potentially node‑positive malignancy, mandating oncologic clearance. The keyed answer D (radical cholecystectomy with en‑bloc resection of liver segments IVb/V and portal lymphadenectomy) reflects the standard of care endorsed by NCCN and AJCC for T1b gallbladder cancer. Alternative options are clearly inferior: observation (A) undertreats nodal risk; adjuvant chemotherapy (B) or radiation (C) are not primary curative therapies for resectable T1b; ERCP with stenting (E) is palliative and inappropriate. The vignette contains no contradictory information and provides adequate detail to identify a single best answer. Medical accuracy: The distinction between T1a (simple cholecystectomy) and T1b (radical resection) is correct and aligns with current oncologic principles. While recent literature suggests select T1b cases may be managed with simple cholecystectomy alone, the item’s recommendation remains the consensus for board‑style assessment. No major inaccuracies. Minimal fix: None required.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-009", "question": "A trauma patient presents with a Zone I retroperitoneal hematoma following a high-speed motor vehicle collision. Hemodynamics are transiently stabilized with fluids. CT scan shows the hematoma is centered around the supramesocolic midline. Intraoperatively, what is the mandated management strategy?", "options": ["Observation if the hematoma is not expanding", "Immediate exploration of the hematoma", "Angiographic embolization", "Packing and temporary closure", "REBOA placement in Zone 1"], "answer": "B", "answer_index": 1, "explanation": "Zone I retroperitoneal hematomas (central, midline) in blunt trauma are presumed to involve the aorta, vena cava, or proximal branches (celiac/SMA). Unlike Zone II (flank/kidney) or Zone III (pelvic) hematomas which may be managed non-operatively or with angioembolization if stable, a Zone I hematoma mandates surgical exploration to rule out or repair catastrophic vascular injury.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. Key stem clues—Zone I retroperitoneal hematoma, supramesocolic midline location, and explicit 'intraoperatively' framing—mandate surgical exploration per ATLS/trauma surgery principles, as these hematomas harbor potential aortic, caval, or proximal visceral vessel injuries. The rationale correctly distinguishes Zone I (central) from Zone II (flank/renal) and Zone III (pelvic) management. Option B is uniquely defensible: immediate exploration is the standard of care when a Zone I hematoma is encountered during laparotomy. Alternatives are appropriately excluded: A (observation) and C (angiography) are reserved for stable Zone II/III hematomas; D (packing) is a damage-control adjunct after exploration, not the primary mandated strategy; E (REBOA) is a resuscitation bridge, not intraoperative management. No contradictions or underspecification. Medical content aligns with current trauma guidelines. Minor nuance: 'transiently stabilized' reinforces the high-risk nature but is not required for the answer. No fix needed.\",\"medical_accuracy_score\":  \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. Key stem clues—Zone I retroperitoneal hematoma, supramesocolic midline location, and explicit 'intraoperatively' framing—mandate surgical exploration per ATLS/trauma surgery principles, as these hematomas harbor potential aortic, caval, or proximal visceral vessel injuries. The rationale correctly distinguishes Zone I (central) from Zone II (flank/renal) and Zone III (pelvic) management. Option B is uniquely defensible: immediate exploration is the standard of care when a Zone I hematoma is encountered during laparotomy. Alternatives are appropriately excluded: A (observation) and C (angiography) are reserved for stable Zone II/III hematomas; D (packing) is a damage-control adjunct after exploration, not the primary mandated strategy; E (REBOA) is a resuscitation bridge, not intraoperative management. No contradictions or underspecification. Medical content aligns with current trauma guidelines. Minor nuance: 'transiently stabilized' reinforces the high-risk nature but is not required for the answer. No fix needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-010", "question": "A 32-year-old female presents with acute vision loss in the left eye and retrobulbar pain. Examination reveals a central scotoma and an afferent pupillary defect. MRI shows enhancement of the left optic nerve. She is diagnosed with optic neuritis. According to the Optic Neuritis Treatment Trial (ONTT), which treatment regimen is contraindicated because it increases the rate of recurrence?", "options": ["Intravenous methylprednisolone followed by oral prednisone", "Oral prednisone alone", "Intravenous immunoglobulin (IVIG)", "Plasma exchange", "Observation alone"], "answer": "B", "answer_index": 1, "explanation": "The ONTT demonstrated that treatment with oral prednisone alone (at standard doses) not only failed to improve visual outcome compared to placebo but actually significantly increased the rate of recurrent optic neuritis. The standard of care is IV methylprednisolone (often followed by an oral taper) or observation.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem’s key discriminating clues are the explicit reference to the Optic Neuritis Treatment Trial (ONTT) and the focus on a treatment that increases recurrence. The ONTT randomized 457 patients to high‑dose IV methylprednisolone (IVMP) followed by oral prednisone, oral prednisone alone (1 mg/kg/day), or placebo. Oral prednisone alone was associated with a statistically significant, roughly 2.5‑fold higher rate of recurrent optic neuritis at two years compared with placebo, whereas IVMP did not increase recurrence and observation was neutral. Consequently, only option B is directly contraindicated by the trial’s data. Options A and E represent accepted management (IVMP or watchful waiting) and do not raise recurrence risk. Options C and D (IVIG, plasma exchange) are not addressed by ONTT and are not standard for typical optic neuritis, so they cannot be the best answer. No internal contradictions or missing critical details are present; the item permits a single best choice. Medical accuracy is gold‑standard: the answer reflects current neuro‑ophthalmology consensus and the ONTT’s long‑term outcomes. Minimal fix: none required; the item is precise as written.\",\n\"medical_accuracy_score\":  \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem’s key discriminating clues are the explicit reference to the Optic Neuritis Treatment Trial (ONTT) and the focus on a treatment that increases recurrence. The ONTT randomized 457 patients to high‑dose IV methylprednisolone (IVMP) followed by oral prednisone, oral prednisone alone (1 mg/kg/day), or placebo. Oral prednisone alone was associated with a statistically significant, roughly 2.5‑fold higher rate of recurrent optic neuritis at two years compared with placebo, whereas IVMP did not increase recurrence and observation was neutral. Consequently, only option B is directly contraindicated by the trial’s data. Options A and E represent accepted management (IVMP or watchful waiting) and do not raise recurrence risk. Options C and D (IVIG, plasma exchange) are not addressed by ONTT and are not standard for typical optic neuritis, so they cannot be the best answer. No internal contradictions or missing critical details are present; the item permits a single best choice. Medical accuracy is gold‑standard: the answer reflects current neuro‑ophthalmology consensus and the ONTT’s long‑term outcomes. Minimal fix: none required; the item is precise as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-011", "question": "A neonate with Down syndrome presents with hepatosplenomegaly and a high white blood cell count consisting of blasts. A diagnosis of Transient Myeloproliferative Disorder (TMD) is made. Mutation analysis of the blasts would most likely reveal a mutation in which gene?", "options": ["JAK2", "GATA1", "RUNX1", "ETV6", "BCR-ABL"], "answer": "B", "answer_index": 1, "explanation": "TMD in Down syndrome is uniquely associated with somatic mutations in the GATA1 gene, which encodes a transcription factor required for erythroid and megakaryocytic differentiation. While TMD often resolves spontaneously, these patients are at increased risk for developing Acute Megakaryoblastic Leukemia (AMKL) later in childhood.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. Key stem clues: neonate with Down syndrome, hepatosplenomegaly, leukocytosis with blasts, diagnosis of Transient Myeloproliferative Disorder (TMD). These findings uniquely point to GATA1 mutation as the driver of TMD in this population. The keyed answer B (GATA1) is definitively supported: somatic GATA1 truncating mutations are pathognomonic for TMD in Down syndrome and are present in nearly all cases. Alternative options are clearly inferior: JAK2 V617F associates with adult myeloproliferative neoplasms; RUNX1 and ETV6 mutations occur in other myeloid malignancies but not specifically TMD; BCR-ABL defines Philadelphia chromosome-positive leukemias unrelated to TMD pathogenesis. No logical issues: the stem provides sufficient discriminating detail, options are mutually exclusive, and the key matches the single best answer. Medical accuracy is gold-standard: the association between GATA1 and TMD in Down syndrome is established in pediatric hematology guidelines, and the risk of subsequent AMKL is correctly noted. Minimal fix: none required; item is board-ready as written.\",\"medical_accuracy_score\":   \t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. Key stem clues: neonate with Down syndrome, hepatosplenomegaly, leukocytosis with blasts, diagnosis of Transient Myeloproliferative Disorder (TMD). These findings uniquely point to GATA1 mutation as the driver of TMD in this population. The keyed answer B (GATA1) is definitively supported: somatic GATA1 truncating mutations are pathognomonic for TMD in Down syndrome and are present in nearly all cases. Alternative options are clearly inferior: JAK2 V617F associates with adult myeloproliferative neoplasms; RUNX1 and ETV6 mutations occur in other myeloid malignancies but not specifically TMD; BCR-ABL defines Philadelphia chromosome-positive leukemias unrelated to TMD pathogenesis. No logical issues: the stem provides sufficient discriminating detail, options are mutually exclusive, and the key matches the single best answer. Medical accuracy is gold-standard: the association between GATA1 and TMD in Down syndrome is established in pediatric hematology guidelines, and the risk of subsequent AMKL is correctly noted. Minimal fix: none required; item is board-ready as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-012", "question": "A 2-year-old boy presents with eczema, thrombocytopenia, and recurrent pyogenic infections. He has small platelets on peripheral smear. Genetic testing reveals a mutation in the WAS gene. Which of the following malignancies is this patient at the highest risk of developing?", "options": ["Non-Hodgkin Lymphoma", "Acute Myeloid Leukemia", "Neuroblastoma", "Hepatoblastoma", "Osteosarcoma"], "answer": "A", "answer_index": 0, "explanation": "Wiskott-Aldrich Syndrome (WAS) is an X-linked disorder characterized by the triad of eczema, immunodeficiency, and thrombocytopenia with small platelets. Due to defective T-cell function and immune surveillance, these patients have a significantly elevated risk of lymphoreticular malignancies, particularly Non-Hodgkin Lymphoma (often EBV-positive).", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid). Verdict: The keyed answer (A – Non‑Hodgkin Lymphoma) is the correct best answer. Key stem clues: 2‑year‑old boy with eczema, thrombocytopenia with small platelets, recurrent pyogenic infections, and a documented WAS gene mutation. This phenotype defines Wiskott‑Aldrich syndrome (WAS), an X‑linked immunodeficiency characterized by defective T‑cell function and impaired immune surveillance. The malignancy risk in WAS is highest for lymphoreticular tumors, especially non‑Hodgkin lymphoma (often EBV‑driven). Alternative options (AML, neuroblastoma, hepatoblastoma, osteosarcoma) are not the predominant malignancies associated with WAS. No internal contradictions or missing data prevent a single best answer. Medical accuracy: The item aligns with current literature and major immunodeficiency guidelines; the stated risk is accurate and the explanation correctly links WAS to NHL. No major inaccuracies. Minimal fix: None required; item is board‑ready.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: The keyed answer (A – Non‑Hodgkin Lymphoma) is the correct best answer. Key stem clues: 2‑year‑old boy with eczema, thrombocytopenia with small platelets, recurrent pyogenic infections, and a documented WAS gene mutation. This phenotype defines Wiskott‑Aldrich syndrome (WAS), an X‑linked immunodeficiency characterized by defective T‑cell function and impaired immune surveillance. The malignancy risk in WAS is highest for lymphoreticular tumors, especially non‑Hodgkin lymphoma (often EBV‑driven). Alternative options (AML, neuroblastoma, hepatoblastoma, osteosarcoma) are not the predominant malignancies associated with WAS. No internal contradictions or missing data prevent a single best answer. Medical accuracy: The item aligns with current literature and major immunodeficiency guidelines; the stated risk is accurate and the explanation correctly links WAS to NHL. No major inaccuracies. Minimal fix: None required; item is board‑ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-013", "question": "A patient with a dual-chamber pacemaker programmed to DDD mode undergoes surgery. A magnet is placed over the device to prevent electromagnetic interference (EMI) from electrocautery. The pacemaker battery is known to be at the 'Elective Replacement Indicator' (ERI) voltage level. What is the most likely response of the pacemaker to the magnet application?", "options": ["Reversion to asynchronous DOO mode at the magnet rate", "Reversion to asynchronous VOO mode at the magnet rate", "No change in mode or rate (magnet response disabled)", "Inhibition of all pacing", "Reversion to VVI mode"], "answer": "C", "answer_index": 2, "explanation": "Normally, magnet application converts a pacemaker to an asynchronous mode (DOO/VOO) at a specific magnet rate. However, many modern pacemakers are programmed to disable the magnet response when the battery voltage drops to the Elective Replacement Indicator (ERI) or End of Life (EOL) level to conserve power or signal the battery status. Therefore, the magnet may fail to protect against EMI in this specific scenario.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict: Correct best answer. Key stem clues: (1) dual-chamber DDD pacemaker, (2) magnet application for EMI protection, (3) battery at Elective Replacement Indicator (ERI) voltage. These clues uniquely point to disabled magnet response, as modern pacemakers conserve power by disabling non-essential features at ERI/EOL. The keyed answer C is defensible because manufacturer specifications commonly disable magnet response when battery voltage drops to ERI, preventing the expected asynchronous pacing. Alternative options are clearly inferior: A/B describe normal magnet behavior (DOO/VOO) that does not occur at ERI; D (inhibition of all pacing) and E (reversion to VVI) are not standard magnet responses. No logical issues exist: the stem provides sufficient detail for discrimination, contains no contradictions, and options are mutually exclusive and comparable. Medical accuracy is excellent: the scenario accurately reflects contemporary pacemaker behavior with critical safety implications—clinicians must recognize that magnet protection may fail at ERI, requiring alternative EMI mitigation strategies. This nuance is board-relevant and clinically essential. No fix required; item is already unambiguous and accurate.\",\n\"medical_accuracy_score\":   \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues: (1) dual-chamber DDD pacemaker, (2) magnet application for EMI protection, (3) battery at Elective Replacement Indicator (ERI) voltage. These clues uniquely point to disabled magnet response, as modern pacemakers conserve power by disabling non-essential features at ERI/EOL. The keyed answer C is defensible because manufacturer specifications commonly disable magnet response when battery voltage drops to ERI, preventing the expected asynchronous pacing. Alternative options are clearly inferior: A/B describe normal magnet behavior (DOO/VOO) that does not occur at ERI; D (inhibition of all pacing) and E (reversion to VVI) are not standard magnet responses. No logical issues exist: the stem provides sufficient detail for discrimination, contains no contradictions, and options are mutually exclusive and comparable. Medical accuracy is excellent: the scenario accurately reflects contemporary pacemaker behavior with critical safety implications—clinicians must recognize that magnet protection may fail at ERI, requiring alternative EMI mitigation strategies. This nuance is board-relevant and clinically essential. No fix required; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-014", "question": "A patient undergoing general anesthesia with desflurane develops a rapid increase in end-tidal CO2 and tachycardia. Malignant Hyperthermia (MH) is suspected. The anesthesia machine is flushed, and dantrolene is administered. Which of the following calcium channel blockers is absolutely contraindicated in the acute management of this patient?", "options": ["Amlodipine", "Diltiazem", "Verapamil", "Nicardipine", "Nimodipine"], "answer": "C", "answer_index": 2, "explanation": "Verapamil (and diltiazem) is contraindicated in the setting of Malignant Hyperthermia, especially when dantrolene is administered. The combination of dantrolene and calcium channel blockers can lead to profound hyperkalemia and cardiovascular collapse/myocardial depression.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem correctly frames an MH crisis with dantrolene administration, asking which calcium channel blocker is contraindicated. Key discriminating findings include MH suspicion and dantrolene use, which historically contraindicates non-dihydropyridine CCBs due to hyperkalemia and cardiovascular collapse risk. However, the rationale explicitly states 'Verapamil (and diltiazem) is contraindicated,' directly acknowledging that both options B and C are equally correct. This creates two defensible answers, violating single-best-answer integrity. While verapamil is correct, diltiazem is pharmacologically equivalent as another non-dihydropyridine CCB with identical concerns. The dihydropyridines (amlodipine, nicardipine, nimodipine) are not implicated. Medical content aligns with traditional anesthesia teaching, though the absolute contraindication is debated in recent literature. The primary flaw is logical: the question structure cannot yield a unique answer when two options share the same mechanism of concern. Minimal fix: Remove diltiazem from the options, leaving verapamil as the sole non-dihydropyridine CCB, restoring single-best-answer validity while preserving the teaching point.\",\"medical_accuracy_score\":  \"3\",\"logical_validity\": false,\"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem correctly frames an MH crisis with dantrolene administration, asking which calcium channel blocker is contraindicated. Key discriminating findings include MH suspicion and dantrolene use, which historically contraindicates non-dihydropyridine CCBs due to hyperkalemia and cardiovascular collapse risk. However, the rationale explicitly states 'Verapamil (and diltiazem) is contraindicated,' directly acknowledging that both options B and C are equally correct. This creates two defensible answers, violating single-best-answer integrity. While verapamil is correct, diltiazem is pharmacologically equivalent as another non-dihydropyridine CCB with identical concerns. The dihydropyridines (amlodipine, nicardipine, nimodipine) are not implicated. Medical content aligns with traditional anesthesia teaching, though the absolute contraindication is debated in recent literature. The primary flaw is logical: the question structure cannot yield a unique answer when two options share the same mechanism of concern. Minimal fix: Remove diltiazem from the options, leaving verapamil as the sole non-dihydropyridine CCB, restoring single-best-answer validity while preserving the teaching point.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-015", "question": "A 65-year-old male presents with new-onset intention tremor and gait ataxia. MRI reveals T2 hyperintensities in the middle cerebellar peduncles (MCP sign). He has a grandson with intellectual disability. What is the molecular mechanism of the grandfather's condition?", "options": ["CGG repeat expansion > 200 causing gene methylation and silencing", "CGG repeat expansion between 55 and 200 causing mRNA toxicity", "CAG repeat expansion causing polyglutamine aggregation", "CTG repeat expansion causing RNA foci formation", "Deletion of the FMR1 gene"], "answer": "B", "answer_index": 1, "explanation": "The patient has Fragile X-associated Tremor/Ataxia Syndrome (FXTAS). This occurs in 'premutation' carriers (55-200 CGG repeats) of the FMR1 gene. Unlike Fragile X syndrome (>200 repeats, gene silencing/methylation), FXTAS is caused by a 'toxic gain-of-function' where elevated levels of FMR1 mRNA containing the repeats sequester RNA-binding proteins, leading to neurotoxicity.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid). Verdict: Correct best answer. The stem's combination of late-onset cerebellar signs (intention tremor, gait ataxia) plus the highly specific middle cerebellar peduncle (MCP) T2 hyperintensity sign uniquely points to Fragile X-associated Tremor/Ataxia Syndrome (FXTAS). The grandson's intellectual disability provides the critical family history clue of an FMR1 mutation in the pedigree. Key discriminating findings: age >50, cerebellar signs, MCP sign, and X-linked inheritance pattern affecting a grandson. Option B correctly identifies the premutation range (55-200 CGG repeats) and the toxic gain-of-function mechanism via elevated mRNA sequestering RNA-binding proteins. Alternative options are definitively incorrect: A describes full mutation Fragile X syndrome (silencing), C describes CAG repeat disorders (e.g., Huntington), D describes myotonic dystrophy, and E is a loss-of-function deletion incompatible with FXTAS pathogenesis. No internal contradictions or missing details prevent unique answer selection. Medical accuracy is excellent: FXTAS mechanism is precisely described and aligns with current consensus. The item is board-style appropriate. Minimal fix: None required; item is valid and accurate as written.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: Correct best answer. The stem's combination of late-onset cerebellar signs (intention tremor, gait ataxia) plus the highly specific middle cerebellar peduncle (MCP) T2 hyperintensity sign uniquely points to Fragile X-associated Tremor/Ataxia Syndrome (FXTAS). The grandson's intellectual disability provides the critical family history clue of an FMR1 mutation in the pedigree. Key discriminating findings: age >50, cerebellar signs, MCP sign, and X-linked inheritance pattern affecting a grandson. Option B correctly identifies the premutation range (55-200 CGG repeats) and the toxic gain-of-function mechanism via elevated mRNA sequestering RNA-binding proteins. Alternative options are definitively incorrect: A describes full mutation Fragile X syndrome (silencing), C describes CAG repeat disorders (e.g., Huntington), D describes myotonic dystrophy, and E is a loss-of-function deletion incompatible with FXTAS pathogenesis. No internal contradictions or missing details prevent unique answer selection. Medical accuracy is excellent: FXTAS mechanism is precisely described and aligns with current consensus. The item is board-style appropriate. Minimal fix: None required; item is valid and accurate as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-016", "question": "A patient with bipolar disorder is stable on valproate. He develops a severe infection and is prescribed meropenem. Within 48 hours, his manic symptoms recur. What is the mechanism of this drug interaction?", "options": ["Meropenem inhibits CYP2C9, increasing valproate toxicity", "Meropenem displaces valproate from albumin", "Meropenem increases the glucuronidation and renal clearance of valproate", "Meropenem acts as a direct dopamine agonist", "Meropenem induces CYP3A4, lowering valproate levels"], "answer": "C", "answer_index": 2, "explanation": "Carbapenems (like meropenem) dramatically reduce serum valproate levels, often by 50-80% within 24 hours. The mechanism involves the inhibition of acylpeptide hydrolase (which normally deconjugates valproate-glucuronide back to valproate) and increased renal clearance of the glucuronide metabolite. This interaction is rapid and can precipitate decompensation.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V (valid). Verdict: The keyed answer (C) is the correct best answer. The stem provides a classic drug interaction scenario: a patient on valproate develops mania shortly after starting meropenem. The key discriminating clue is the rapid onset (48 h) and the known carbapenem–valproate interaction. Option C correctly captures the mechanism: carbapenems inhibit acylpeptide hydrolase, blocking regeneration of valproate from its glucuronide and thereby increasing renal clearance of the conjugate. The other options are clearly incorrect: meropenem does not inhibit CYP2C9 (A), does not displace valproate from albumin (B), lacks dopamine agonist activity (D), and does not induce CYP3A4 (E). The only minor medical accuracy issue is that option C states “increases the glucuronidation,” whereas the actual effect is inhibition of deconjugation; however, the net result—enhanced clearance of valproate—is correctly conveyed. No logical contradictions or missing details prevent a single best answer. Minimal fix: rephrase option C to “Meropenem inhibits deconjugation of valproate‑glucuronide, increasing renal clearance of valproate.”\",\n\"medical_accuracy_score\":   \t\"4\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (valid). Verdict: The keyed answer (C) is the correct best answer. The stem provides a classic drug interaction scenario: a patient on valproate develops mania shortly after starting meropenem. The key discriminating clue is the rapid onset (48 h) and the known carbapenem–valproate interaction. Option C correctly captures the mechanism: carbapenems inhibit acylpeptide hydrolase, blocking regeneration of valproate from its glucuronide and thereby increasing renal clearance of the conjugate. The other options are clearly incorrect: meropenem does not inhibit CYP2C9 (A), does not displace valproate from albumin (B), lacks dopamine agonist activity (D), and does not induce CYP3A4 (E). The only minor medical accuracy issue is that option C states “increases the glucuronidation,” whereas the actual effect is inhibition of deconjugation; however, the net result—enhanced clearance of valproate—is correctly conveyed. No logical contradictions or missing details prevent a single best answer. Minimal fix: rephrase option C to “Meropenem inhibits deconjugation of valproate‑glucuronide, increasing renal clearance of valproate.”", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-017", "question": "In the forensic evaluation of a defendant's competency to stand trial (CST), which legal standard is the primary precedent in the United States?", "options": ["Durham v. United States", "Dusky v. United States", "M'Naghten Rule", "Tarasoff v. Regents of the University of California", "Ford v. Wainwright"], "answer": "B", "answer_index": 1, "explanation": "Dusky v. United States (1960) established the standard for Competency to Stand Trial. The defendant must have a 'sufficient present ability to consult with his lawyer with a reasonable degree of rational understanding' and a 'rational as well as factual understanding of the proceedings against him.' M'Naghten and Durham relate to the insanity defense (NGRI), not competency.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem explicitly asks for the primary legal precedent for competency to stand trial (CST) in the United States. Key discriminating clue is the precise term 'competency to stand trial.' Dusky v. United States (1960) established the two-pronged CST standard: sufficient present ability to consult counsel with rational understanding and rational/factual understanding of proceedings. The keyed answer B aligns perfectly with this landmark Supreme Court precedent. Alternative options are clearly distinguishable: Durham (insanity defense product test), M'Naghten (insanity right/wrong test), Tarasoff (therapist duty to warn), and Ford (competency to be executed). No internal contradictions exist, and no critical details are missing. The item requires only widely accepted forensic psychiatric knowledge. Medical accuracy is excellent: Dusky remains the controlling Supreme Court standard for CST, and the rationale correctly differentiates it from criminal responsibility standards. This is a board-style question with precise terminology and appropriate distractors that test common confusion points between CST and insanity. Minimal fix: None required; item is examination-ready as written.\",\"medical_accuracy_score\":   \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem explicitly asks for the primary legal precedent for competency to stand trial (CST) in the United States. Key discriminating clue is the precise term 'competency to stand trial.' Dusky v. United States (1960) established the two-pronged CST standard: sufficient present ability to consult counsel with rational understanding and rational/factual understanding of proceedings. The keyed answer B aligns perfectly with this landmark Supreme Court precedent. Alternative options are clearly distinguishable: Durham (insanity defense product test), M'Naghten (insanity right/wrong test), Tarasoff (therapist duty to warn), and Ford (competency to be executed). No internal contradictions exist, and no critical details are missing. The item requires only widely accepted forensic psychiatric knowledge. Medical accuracy is excellent: Dusky remains the controlling Supreme Court standard for CST, and the rationale correctly differentiates it from criminal responsibility standards. This is a board-style question with precise terminology and appropriate distractors that test common confusion points between CST and insanity. Minimal fix: None required; item is examination-ready as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-018", "question": "A 40-year-old female presents with a 3 cm mass in the tail of the pancreas. CT imaging shows a well-circumscribed lesion with peripheral calcification. EUS-FNA is non-diagnostic but shows glycogen-rich cuboidal cells. What is the most likely diagnosis?", "options": ["Serous cystadenoma", "Mucinous cystic neoplasm", "Solid pseudopapillary neoplasm", "Pancreatic neuroendocrine tumor", "Acinar cell carcinoma"], "answer": "A", "answer_index": 0, "explanation": "Serous cystadenomas are benign lesions often found in the pancreatic tail. The classic description includes a 'honeycomb' appearance and a central scar with calcification (though peripheral calcification can occur). The key histologic feature is glycogen-rich cuboidal cells (clear cells) that stain positive for PAS. They have virtually no malignant potential.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best answer. Key stem clues: 3 cm pancreatic tail mass in a 40-year-old woman; well-circumscribed lesion with peripheral calcification; EUS-FNA showing glycogen-rich cuboidal cells. The presence of glycogen-rich cuboidal cells is pathognomonic for serous cystadenoma, which typically occurs in the pancreatic tail of women and can demonstrate calcifications. Alternative diagnoses are excluded: mucinous cystic neoplasms show mucinous epithelium, solid pseudopapillary neoplasms have distinct architecture, neuroendocrine tumors show neuroendocrine features, and acinar cell carcinomas show acinar differentiation. Main logical issue: Minor inconsistency in stating the FNA is 'non-diagnostic but shows' characteristic cells—identifying pathognomonic cells renders the sample diagnostic. This does not prevent selecting a unique best answer. Main medical accuracy issue: None. The description aligns with current pathology standards: serous cystadenomas are benign, glycogen-rich (clear cell) lesions, PAS-positive, with minimal malignant potential. Minimal fix: Change 'EUS-FNA is non-diagnostic but shows' to 'EUS-FNA shows' to eliminate contradictory phrasing.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues: 3 cm pancreatic tail mass in a 40-year-old woman; well-circumscribed lesion with peripheral calcification; EUS-FNA showing glycogen-rich cuboidal cells. The presence of glycogen-rich cuboidal cells is pathognomonic for serous cystadenoma, which typically occurs in the pancreatic tail of women and can demonstrate calcifications. Alternative diagnoses are excluded: mucinous cystic neoplasms show mucinous epithelium, solid pseudopapillary neoplasms have distinct architecture, neuroendocrine tumors show neuroendocrine features, and acinar cell carcinomas show acinar differentiation. Main logical issue: Minor inconsistency in stating the FNA is 'non-diagnostic but shows' characteristic cells—identifying pathognomonic cells renders the sample diagnostic. This does not prevent selecting a unique best answer. Main medical accuracy issue: None. The description aligns with current pathology standards: serous cystadenomas are benign, glycogen-rich (clear cell) lesions, PAS-positive, with minimal malignant potential. Minimal fix: Change 'EUS-FNA is non-diagnostic but shows' to 'EUS-FNA shows' to eliminate contradictory phrasing.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-019", "question": "During a laparoscopic inguinal hernia repair (TEP), the surgeon encounters significant bleeding from an aberrant vessel crossing the superior pubic ramus, connecting the external iliac and obturator systems. This vessel is known as:", "options": ["Circle of Willis", "Corona Mortis", "Arc of Riolan", "Marginal Artery of Drummond", "Batson's Plexus"], "answer": "B", "answer_index": 1, "explanation": "The 'Corona Mortis' (Crown of Death) is a vascular connection between the obturator and external iliac systems (usually an aberrant obturator artery arising from the inferior epigastric). It crosses the superior pubic ramus in the Space of Retzius and is at high risk of injury during laparoscopic hernia repair or pelvic trauma, leading to difficult-to-control hemorrhage.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: The keyed answer B (Corona Mortis) is the correct and uniquely defensible best answer. Key stem clues—laparoscopic TEP inguinal hernia repair, bleeding from an aberrant vessel crossing the superior pubic ramus, and a connection between external iliac and obturator systems—precisely describe the Corona Mortis. This anatomic variant (typically an aberrant obturator artery arising from the inferior epigastric) is present in 25-40% of individuals and is notorious for catastrophic hemorrhage during pelvic surgery. No logical issues: the vignette is internally consistent, contains no contradictions, and provides sufficient detail for a single best answer. Alternative options are clearly incorrect: Circle of Willis (cerebral), Arc of Riolan and Marginal Artery of Drummond (colonic mesenteric), and Batson's Plexus (vertebral venous) are anatomically unrelated to the pelvis. Medical accuracy is excellent: the description aligns with contemporary surgical anatomy and standard board references. No fix required; the item is board-ready as written.\",\"medical_accuracy_score\":  \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: The keyed answer B (Corona Mortis) is the correct and uniquely defensible best answer. Key stem clues—laparoscopic TEP inguinal hernia repair, bleeding from an aberrant vessel crossing the superior pubic ramus, and a connection between external iliac and obturator systems—precisely describe the Corona Mortis. This anatomic variant (typically an aberrant obturator artery arising from the inferior epigastric) is present in 25-40% of individuals and is notorious for catastrophic hemorrhage during pelvic surgery. No logical issues: the vignette is internally consistent, contains no contradictions, and provides sufficient detail for a single best answer. Alternative options are clearly incorrect: Circle of Willis (cerebral), Arc of Riolan and Marginal Artery of Drummond (colonic mesenteric), and Batson's Plexus (vertebral venous) are anatomically unrelated to the pelvis. Medical accuracy is excellent: the description aligns with contemporary surgical anatomy and standard board references. No fix required; the item is board-ready as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-020", "question": "A patient with a history of rhegmatogenous retinal detachment repair with silicone oil tamponade presents with inferior visual field loss in the same eye. Intraocular pressure is 35 mmHg. Gonioscopy reveals silicone oil emulsification in the superior angle. What is the mechanism of this glaucoma?", "options": ["Pupillary block", "Trabecular meshwork obstruction by emulsified oil droplets", "Ciliary body inflammation", "Schlemm's canal collapse", "Angle closure due to anterior displacement of the lens-iris diaphragm"], "answer": "B", "answer_index": 1, "explanation": "Silicone oil is lighter than water (aqueous humor) and floats. Over time, it can emulsify into small droplets. These droplets float into the superior angle (unlike pigment or pseudoexfoliation material which settles inferiorly) and physically obstruct the trabecular meshwork, causing secondary open-angle glaucoma. This is sometimes called 'inverse hypopyon'.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict: Correct best answer. Key stem clues: prior silicone oil tamponade, elevated IOP (35 mm Hg), gonioscopic evidence of emulsified silicone oil droplets in the superior angle. These findings point to secondary open‑angle glaucoma caused by physical obstruction of the trabecular meshwork (TM) by floating oil droplets, a classic mechanism of silicone‑oil‑induced glaucoma (often termed ‘inverse hypopyon’). The other options are inconsistent: pupillary block (A) would produce a shallow anterior chamber and iris bombe, not described; ciliary body inflammation (C) lacks uveitic signs; Schlemm’s canal collapse (D) is not a recognized sequela of silicone oil; angle closure from forward lens‑iris displacement (E) would also show a shallow chamber and is not supported by the presence of oil in the angle. No internal contradictions or missing data prevent a single best answer. Medical accuracy: The explanation aligns with current ophthalmic literature and guidelines; silicone oil is lighter than aqueous, emulsifies, rises to the superior angle, and obstructs the TM, producing elevated IOP. No factual errors. Minimal fix: None required.\",\n\"medical_accuracy_score\":  \t \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues: prior silicone oil tamponade, elevated IOP (35 mm Hg), gonioscopic evidence of emulsified silicone oil droplets in the superior angle. These findings point to secondary open‑angle glaucoma caused by physical obstruction of the trabecular meshwork (TM) by floating oil droplets, a classic mechanism of silicone‑oil‑induced glaucoma (often termed ‘inverse hypopyon’). The other options are inconsistent: pupillary block (A) would produce a shallow anterior chamber and iris bombe, not described; ciliary body inflammation (C) lacks uveitic signs; Schlemm’s canal collapse (D) is not a recognized sequela of silicone oil; angle closure from forward lens‑iris displacement (E) would also show a shallow chamber and is not supported by the presence of oil in the angle. No internal contradictions or missing data prevent a single best answer. Medical accuracy: The explanation aligns with current ophthalmic literature and guidelines; silicone oil is lighter than aqueous, emulsifies, rises to the superior angle, and obstructs the TM, producing elevated IOP. No factual errors. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]